Healthcare News and Research

Latest Healthcare News and Research

Inconsistent definition and management of deadly pathogens could contribute to spread of infections

Infection control practices for detecting and treating patients infected with emerging multidrug-resistant gram-negative bacteria (MDR-GNB) vary significantly between hospitals.

10 Mar 2014

Study: Severe C. difficile infections occur among children who prescribed antibiotics in doctor's offices

The majority of pediatric Clostridium difficile infections, which are bacterial infections that cause severe diarrhea and are potentially life-threatening, occur among children in the general community who recently took antibiotics prescribed in doctor's offices for other conditions, according to a new study by the Centers for Disease Control and Prevention published this week in Pediatrics.

10 Mar 2014

Food safety measures taken by hospital minimize risk to food handlers

A new study found more than 80 percent of raw chicken used in hospitals in food for patients and staff was contaminated with a form of antibiotic resistant bacteria called extended-spectrum beta-lactamase (ESBL) producing E. coli. While sufficient preparation eliminated the presence of bacteria, poultry meat delivered to hospital kitchens remains a potential point of entry for these dangerous bacteria into the hospital.

10 Mar 2014

N.H. Senate, led by GOP, votes to expand Medicaid

Seven Republicans joined Democrats to pass the bill, which now goes to the Democratic-controlled House. Meanwhile, tensions are rising in Virginia on the issue as Republicans in the House hold out against the governor's offensive, and in Pennsylvania, the Republican governor amends his requirements for an expansion.

10 Mar 2014

Dr. Daniel D. Von Hoff named one of ASCO's 50 Oncology Luminaries

In association with its 50th anniversary, the American Society of Clinical Oncology has named Dr. Daniel D. Von Hoff one of ASCO's 50 Oncology Luminaries, celebrating 50 doctors who over the past half-century have significantly advanced cancer care.

9 Mar 2014

Aetna honored with 2014 Innovation in Reducing Health Care Disparities Award

Aetna was honored today by the National Business Group on Health (NBGH) with the 2014 Innovation in Reducing Health Care Disparities Award. Aetna is a three-time recipient of the award that recognizes organizations for their commitment to equality in health care and exceptional support for cultural diversity.

8 Mar 2014

Obama gives Latinos full court press

The president appeared at a town-hall-style event Thursday, hosted by Spanish-language media outlets, to urge Latinos to sign up for insurance options made available by the health law before open enrollment ends March 31.

8 Mar 2014

Aptel Research releases newest report Patient Voices Series Rheumatoid Arthritis

Aptel Research, a specialty marketing research and consulting company that provides actionable strategic insights to the pharmaceutical and biotech industries, released its newest report Patient Voices Series Rheumatoid Arthritis (US).

8 Mar 2014

Teva launches generic Xeloda Tablets in the U.S.

Teva Pharmaceutical Industries Ltd. announces the launch of the generic equivalent to Xeloda (Capecitabine) Tablets, 150 MG and 500 MG, in the United States. Xeloda is marketed by Genentech in the United States.

8 Mar 2014

Parents with bipolar disorder feel control by monitoring kids' moods

The majority of parents with bipolar disorder monitor their children's moods, which helps them feel in control of their child's wellbeing, show US study results.

7 Mar 2014

MD² commemorates 18 years of practicing highly personalized care

Widely credited with originating the concept of concierge medicine, MD² celebrates 18 years of practicing highly personalized care.

7 Mar 2014

Longtime allies team up to create Penn Medicine/CHOP Friedreich's Ataxia Center of Excellence

Three longtime allies have joined forces to create the new Penn Medicine/CHOP Friedreich's Ataxia Center of Excellence.

7 Mar 2014

First Edition: March 7, 2014

Today's headlines include stories about new studies that attempt to measure the health law's headway in signing up uninsured Americans for health coverage.

7 Mar 2014

Simple online tool helps predict patient's risk of complications following surgery

The presence - or absence - of complications following surgery is a strong indicator of which patients are likely to be readmitted to the hospital in the 30 days following their procedure, according to a study published today in JAMA Surgery.

7 Mar 2014

Columbia Laboratories repurchases Actavis' block of shares at advantageous price

Columbia Laboratories, Inc. announced today that the Company has repurchased 1.4 million shares of its common stock, par value $0.01 per share, from Coventry Acquisition, LLC, a subsidiary of Actavis Inc. (Actavis), at $6.08 per share, which represents a 10.75% discount to the closing price on Thursday, March 6, 2014.

7 Mar 2014

Agendia co-founder to be honored with 2014 European Union Prize for Women Innovators

Agendia co-founder Laura van 't Veer, Ph.D., will receive a 2014 European Union Prize for Women Innovators in ceremonies next Monday. Dr. van 't Veer, of the Netherlands, is the inventor of Agendia's MammaPrint® breast cancer test.

7 Mar 2014

Scientists throw light on genetic mutation that causes particularly severe genetic disease ARVC5

The genetic disease ARVC leads to sudden cardiac death and is more common than it has been hitherto assumed. This is reported by an international team of researchers headed by Prof Dr Hendrik Milting from the Heart and Diabetes Center NRW in the "European Heart Journal".

7 Mar 2014

Treating long wait-times dictate long-term success of spinal cord stimulation therapy

Success rates soared to 75% for patients who waited less than 2 years for a spinal cord stimulator (SCS) implant, compared with 15% for patients whose implants happened 20 years after the onset of pain, according to a retrospective analysis.

7 Mar 2014

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

Incyte Corporation (Nasdaq: INCY) today announced that a pivotal Phase III trial of ruxolitinib compared to best available therapy in patients with polycythemia vera who are resistant to or intolerant of hydroxyurea has met its primary endpoint of achieving phlebotomy independence and reducing spleen size by 35 percent or more.

7 Mar 2014

Researchers examine association between diabetes and obesity

It's by now well established that obesity is a major risk factor for diabetes. But what exactly is it about extra body fat that leads to insulin resistance and blood glucose elevation, the hallmarks of diabetes?

7 Mar 2014

Healthcare News and Research

Latest Healthcare News and Research

Inconsistent definition and management of deadly pathogens could contribute to spread of infections

Study: Severe C. difficile infections occur among children who prescribed antibiotics in doctor's offices

Food safety measures taken by hospital minimize risk to food handlers

N.H. Senate, led by GOP, votes to expand Medicaid

Dr. Daniel D. Von Hoff named one of ASCO's 50 Oncology Luminaries

Aetna honored with 2014 Innovation in Reducing Health Care Disparities Award

Obama gives Latinos full court press

Aptel Research releases newest report Patient Voices Series Rheumatoid Arthritis

Teva launches generic Xeloda Tablets in the U.S.

Parents with bipolar disorder feel control by monitoring kids' moods

MD² commemorates 18 years of practicing highly personalized care

Longtime allies team up to create Penn Medicine/CHOP Friedreich's Ataxia Center of Excellence

First Edition: March 7, 2014

Simple online tool helps predict patient's risk of complications following surgery

Columbia Laboratories repurchases Actavis' block of shares at advantageous price

Agendia co-founder to be honored with 2014 European Union Prize for Women Innovators

Scientists throw light on genetic mutation that causes particularly severe genetic disease ARVC5

Treating long wait-times dictate long-term success of spinal cord stimulation therapy

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

Researchers examine association between diabetes and obesity

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in